{"title":"COPET研究发现,生物量暴露作为COPD病因型的临床相关性。","authors":"Esra Ertan Yazar MD, PhD , Nilgün Demirci MD, PhD , Burcu Arpınar Yiğitbaş MD, PhD , Mukadder Çalıkoğlu MD, PhD , Gazi Gülbaş MD, PhD , Muzaffer Onur Turan MD, PhD , Hülya Şahin MD, PhD , Nurhan Sarıoğlu MD, PhD , Nevin Taci Hoca MD, PhD , Fulsen Bozkuş MD, PhD , Seda Tural MD, PhD , Nihal Arzu Mirici MD, PhD , Nalan Ogan MD, PhD , Burcu Yormaz MD, PhD , Ayperi Öztürk MD, PhD , Filiz Koşar MD, PhD , Evrim Eylem Akpınar MD, PhD , Gülşah Günlüoğlu MD, PhD , Burak Mete MD, PhD , Can Öztürk MD, PhD , Mecit Süerdem MD, PhD","doi":"10.1016/j.amjms.2025.07.001","DOIUrl":null,"url":null,"abstract":"<div><h3>Purpose</h3><div>The finding that COPD can also develop in non-smokers has led to further investigations of etiologic causes other than smoking. This study evaluated the relationship between tobacco smoking and/or biomass-burning smoke exposure (BBS) and the demographic, clinical, and prognostic characteristics of individuals with COPD.</div></div><div><h3>Methods</h3><div>A total of 1129 stable COPD patients from the COPET study were retrospectively analyzed. The patients were divided into three groups: the COPD-B group (<em>n</em> = 52), which included patients who were solely BBS; the COPD-C group (<em>n</em> = 634), which included patients who exclusively tobacco smoking; and the COPD-BC group (<em>n</em> = 443), which included patients with both BBS and tobacco smoking.</div></div><div><h3>Results</h3><div>The average age of the patients was 65.8 ± 9.1 years, and 87.4 % of them were men. In the COPD-B group, the following factors were significantly greater compared to the COPD-C and COPD-BC groups: age (<em>p</em> = 0.001), BMI (<em>p</em> = 0.001), percentage of female patients (<em>p</em> < 0.001), FEV<sub>1</sub>/FVC ratio (<em>p</em> = 0.014), eosinophil count (<em>p</em> < 0.001), ADO score (<em>p</em> < 0.001), and the proportion of patients with frequent exacerbations (<em>p</em> = 0.013). Thorax CT scans showed that the COPD-BC group had a greater incidence of bronchiectasis and emphysema than the COPD-B and COPD-C groups (<em>p</em> < 0.001).</div></div><div><h3>Conclusions</h3><div>This study highlights significant clinical and radiological differences among COPD patients based on tobacco smoking and BBS, which may substantially impact COPD outcomes, including exacerbations and prognosis.</div></div>","PeriodicalId":55526,"journal":{"name":"American Journal of the Medical Sciences","volume":"370 4","pages":"Pages 365-370"},"PeriodicalIF":1.8000,"publicationDate":"2025-07-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"COPET study findings regarding the clinical relevance of biomass exposure as an etiotype in COPD\",\"authors\":\"Esra Ertan Yazar MD, PhD , Nilgün Demirci MD, PhD , Burcu Arpınar Yiğitbaş MD, PhD , Mukadder Çalıkoğlu MD, PhD , Gazi Gülbaş MD, PhD , Muzaffer Onur Turan MD, PhD , Hülya Şahin MD, PhD , Nurhan Sarıoğlu MD, PhD , Nevin Taci Hoca MD, PhD , Fulsen Bozkuş MD, PhD , Seda Tural MD, PhD , Nihal Arzu Mirici MD, PhD , Nalan Ogan MD, PhD , Burcu Yormaz MD, PhD , Ayperi Öztürk MD, PhD , Filiz Koşar MD, PhD , Evrim Eylem Akpınar MD, PhD , Gülşah Günlüoğlu MD, PhD , Burak Mete MD, PhD , Can Öztürk MD, PhD , Mecit Süerdem MD, PhD\",\"doi\":\"10.1016/j.amjms.2025.07.001\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Purpose</h3><div>The finding that COPD can also develop in non-smokers has led to further investigations of etiologic causes other than smoking. This study evaluated the relationship between tobacco smoking and/or biomass-burning smoke exposure (BBS) and the demographic, clinical, and prognostic characteristics of individuals with COPD.</div></div><div><h3>Methods</h3><div>A total of 1129 stable COPD patients from the COPET study were retrospectively analyzed. The patients were divided into three groups: the COPD-B group (<em>n</em> = 52), which included patients who were solely BBS; the COPD-C group (<em>n</em> = 634), which included patients who exclusively tobacco smoking; and the COPD-BC group (<em>n</em> = 443), which included patients with both BBS and tobacco smoking.</div></div><div><h3>Results</h3><div>The average age of the patients was 65.8 ± 9.1 years, and 87.4 % of them were men. In the COPD-B group, the following factors were significantly greater compared to the COPD-C and COPD-BC groups: age (<em>p</em> = 0.001), BMI (<em>p</em> = 0.001), percentage of female patients (<em>p</em> < 0.001), FEV<sub>1</sub>/FVC ratio (<em>p</em> = 0.014), eosinophil count (<em>p</em> < 0.001), ADO score (<em>p</em> < 0.001), and the proportion of patients with frequent exacerbations (<em>p</em> = 0.013). Thorax CT scans showed that the COPD-BC group had a greater incidence of bronchiectasis and emphysema than the COPD-B and COPD-C groups (<em>p</em> < 0.001).</div></div><div><h3>Conclusions</h3><div>This study highlights significant clinical and radiological differences among COPD patients based on tobacco smoking and BBS, which may substantially impact COPD outcomes, including exacerbations and prognosis.</div></div>\",\"PeriodicalId\":55526,\"journal\":{\"name\":\"American Journal of the Medical Sciences\",\"volume\":\"370 4\",\"pages\":\"Pages 365-370\"},\"PeriodicalIF\":1.8000,\"publicationDate\":\"2025-07-09\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"American Journal of the Medical Sciences\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0002962925010985\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"MEDICINE, GENERAL & INTERNAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"American Journal of the Medical Sciences","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0002962925010985","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
COPET study findings regarding the clinical relevance of biomass exposure as an etiotype in COPD
Purpose
The finding that COPD can also develop in non-smokers has led to further investigations of etiologic causes other than smoking. This study evaluated the relationship between tobacco smoking and/or biomass-burning smoke exposure (BBS) and the demographic, clinical, and prognostic characteristics of individuals with COPD.
Methods
A total of 1129 stable COPD patients from the COPET study were retrospectively analyzed. The patients were divided into three groups: the COPD-B group (n = 52), which included patients who were solely BBS; the COPD-C group (n = 634), which included patients who exclusively tobacco smoking; and the COPD-BC group (n = 443), which included patients with both BBS and tobacco smoking.
Results
The average age of the patients was 65.8 ± 9.1 years, and 87.4 % of them were men. In the COPD-B group, the following factors were significantly greater compared to the COPD-C and COPD-BC groups: age (p = 0.001), BMI (p = 0.001), percentage of female patients (p < 0.001), FEV1/FVC ratio (p = 0.014), eosinophil count (p < 0.001), ADO score (p < 0.001), and the proportion of patients with frequent exacerbations (p = 0.013). Thorax CT scans showed that the COPD-BC group had a greater incidence of bronchiectasis and emphysema than the COPD-B and COPD-C groups (p < 0.001).
Conclusions
This study highlights significant clinical and radiological differences among COPD patients based on tobacco smoking and BBS, which may substantially impact COPD outcomes, including exacerbations and prognosis.
期刊介绍:
The American Journal of The Medical Sciences (AJMS), founded in 1820, is the 2nd oldest medical journal in the United States. The AJMS is the official journal of the Southern Society for Clinical Investigation (SSCI). The SSCI is dedicated to the advancement of medical research and the exchange of knowledge, information and ideas. Its members are committed to mentoring future generations of medical investigators and promoting careers in academic medicine. The AJMS publishes, on a monthly basis, peer-reviewed articles in the field of internal medicine and its subspecialties, which include:
Original clinical and basic science investigations
Review articles
Online Images in the Medical Sciences
Special Features Include:
Patient-Centered Focused Reviews
History of Medicine
The Science of Medical Education.